Tra-PVol shows enhanced uptake and potency in HER2-high SKOV-3 cells, superior tumor deposition (IP > IV) in vivo, suppresses intraperitoneal metastasis, prolongs survival, and maintains low toxicity versus Vol. Here, ERBB2 is linked to neoplasm.